M Stempniak

431 total citations
10 papers, 357 citations indexed

About

M Stempniak is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, M Stempniak has authored 10 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in M Stempniak's work include Monoclonal and Polyclonal Antibodies Research (6 papers), T-cell and B-cell Immunology (3 papers) and Glycosylation and Glycoproteins Research (1 paper). M Stempniak is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), T-cell and B-cell Immunology (3 papers) and Glycosylation and Glycoproteins Research (1 paper). M Stempniak collaborates with scholars based in United States and Poland. M Stempniak's co-authors include Richard H. Weisbart, Andrew L. Wong, Donald J. Zack, Clare T. Taylor, B R Nodes, Zuzana Hostomska, Zdeněk Hostomský, Debra Zack, Kevin Ferreri and Scott Harris and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Oncotarget.

In The Last Decade

M Stempniak

10 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Stempniak United States 8 153 139 126 87 45 10 357
R N Jenkins United States 13 110 0.7× 193 1.4× 104 0.8× 79 0.9× 53 1.2× 18 441
Brigitte Blanchard France 11 112 0.7× 249 1.8× 92 0.7× 41 0.5× 58 1.3× 13 413
G. Riethmüller Germany 9 46 0.3× 153 1.1× 108 0.9× 74 0.9× 19 0.4× 17 295
R D Sontheimer United States 10 121 0.8× 266 1.9× 90 0.7× 153 1.8× 97 2.2× 12 522
R G Oldroyd United Kingdom 8 108 0.7× 329 2.4× 140 1.1× 33 0.4× 47 1.0× 13 518
Y Horiuchi Japan 12 136 0.9× 108 0.8× 96 0.8× 38 0.4× 43 1.0× 23 373
J.A. van Roon Netherlands 8 97 0.6× 160 1.2× 53 0.4× 188 2.2× 17 0.4× 19 420
Henri Isliker Switzerland 11 142 0.9× 222 1.6× 160 1.3× 34 0.4× 33 0.7× 23 501
Christelle Capini France 7 72 0.5× 267 1.9× 100 0.8× 103 1.2× 20 0.4× 9 383
Tony Meager United Kingdom 3 84 0.5× 259 1.9× 100 0.8× 23 0.3× 24 0.5× 5 383

Countries citing papers authored by M Stempniak

Since Specialization
Citations

This map shows the geographic impact of M Stempniak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Stempniak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Stempniak more than expected).

Fields of papers citing papers by M Stempniak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Stempniak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Stempniak. The network helps show where M Stempniak may publish in the future.

Co-authorship network of co-authors of M Stempniak

This figure shows the co-authorship network connecting the top 25 collaborators of M Stempniak. A scholar is included among the top collaborators of M Stempniak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Stempniak. M Stempniak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wu, Katherine, Eleanor Dagostino, Mario Meng-Chiang Kuo, et al.. (2018). TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with arginine deiminase. Oncotarget. 9(97). 36914–36928. 18 indexed citations
2.
Kornbluth, Richard S., M Stempniak, & Geoffrey W. Stone. (2012). Design of CD40 Agonists and Their Use in Growing B Cells for Cancer Immunotherapy. International Reviews of Immunology. 31(4). 279–288. 26 indexed citations
3.
Weisbart, Richard H., M Stempniak, Scott Harris, Debra Zack, & Kevin Ferreri. (1998). An Autoantibody is Modified for Use as a Delivery System to Target the Cell Nucleus: Therapeutic Implications. Journal of Autoimmunity. 11(5). 539–546. 48 indexed citations
4.
Stempniak, M, Zuzana Hostomska, B R Nodes, & Zdeněk Hostomský. (1997). The NS3 proteinase domain of hepatitis C virus is a zinc-containing enzyme. Journal of Virology. 71(4). 2881–2886. 58 indexed citations
5.
Zack, Donald J., M Stempniak, Andrew L. Wong, Clare T. Taylor, & Richard H. Weisbart. (1996). Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody. The Journal of Immunology. 157(5). 2082–2088. 101 indexed citations
6.
Zack, Debra, Andrew L. Wong, M Stempniak, & Richard H. Weisbart. (1995). Two kappa immunoglobulin light chains are secreted by an anti-DNA hybridoma: Implications for isotypic exclusion. Molecular Immunology. 32(17-18). 1345–1353. 13 indexed citations
7.
Zack, Donald J., M Stempniak, Andrew L. Wong, & Richard H. Weisbart. (1995). Localization of an Fc-binding reactivity to the constant region of human IgG4. Implications for the pathogenesis of rheumatoid arthritis. The Journal of Immunology. 155(10). 5057–5063. 48 indexed citations
8.
Zack, Donald J., Kazuhiro Yamamoto, Andrew L. Wong, et al.. (1995). DNA mimics a self-protein that may be a target for some anti-DNA antibodies in systemic lupus erythematosus.. The Journal of Immunology. 154(4). 1987–1994. 39 indexed citations
9.
Schollenberger, A., et al.. (1992). Lymphocyte subpopulations in peripheral blood of pregnant sows.. PubMed. 32(3-4). 35–46. 3 indexed citations
10.
Stempniak, M, et al.. (1988). Ability of peripheral blood neutrophils from patients with infectious bronchial asthma to engulf latex particles and reduce nitroblue tetrazolium.. PubMed. 36(1). 55–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026